BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2017
View Archived Issues
Tonix discloses successful synthesis of potential smallpox-preventing vaccine
Read More
Staten Biotech exercises option to license ARGX-116 from collaboration with argenx
Read More
Lin BioScience licenses CDC7 inhibitor from Columbia University and Memorial Sloan Kettering
Read More
XW Laboratories licenses mitochondria targeted bis-nitroxide compounds from University of Pittsburgh
Read More
APPROACH phase III study of volanesorsen in familial chylomicronemia syndrome meets primary endpoint
Read More
Novan to proceed with SB-204 development
Read More
Galectin reports phase IIa findings on GR-MD-02 in plaque psoriasis
Read More
RgIA4 prevents chemotherapy-induced neuropathic pain in preclinical models
Read More
Fixed-dose combination of oxybutynin and pilocarpine is effective in treating hyperhidrosis
Read More
European Commission approves Ledaga for mycosis fungoides-type CTCL
Read More
First-in-human study of IPI-549 presented at Targeted Anticancer Therapies conference
Read More
IMDC recommends continuation of phase IIb study of BGS-649 for hypogonadotropic hypogonadism
Read More
Ataxion to merge with Luc Therapeutics
Read More
Grant supports Novogen's next-generation anti-tropomyosin program
Read More
Deciphera initiates phase I study of DCC-3014
Read More
Promising topline data from phase III GENUINE study of TG-1101 in CLL
Read More
FDA clears IND for ADXS-NEO
Read More
SOX17 found to be a prognostic factor in endometrial carcinoma
Read More
FDA lifts clinical hold on phase I trials of vadastuximab talirine
Read More
FDA acknowledges filing over protest of Translarna NDA for DMD
Read More
Eli Lilly identifies novel calcitonin gene-related peptide receptor antagonists
Read More
Grants support development by Vaxess of microneedle vaccines for polio, measles and rubella
Read More
Boehringer Ingelheim discloses epithelial sodium channel blockers
Read More
Vertex to acquire Concert's CTP-656 for cystic fibrosis
Read More
FDA and EMA accept for filing ertugliflozin submissions
Read More
Homer-2 expression has prognostic significance in endometrial cancer
Read More